150 results about "Proton magnetic resonance" patented technology

According to one of the aspects of an MRI apparatus of the present invention, the MRI apparatus includes an imaging data acquiring unit and a blood flow information generating unit. The imaging data acquiring unit acquires imaging data from an imaging region including myocardium, without using a contrast medium, by applying a spatial selective excitation pulse to a region including at least a part of an ascending aorta for distinguishably displaying inflowing blood flowing into the imaging region. The blood flow information generating unit generates blood flow image data based on the imaging data.

An multi-modality imaging system for imaging of an object under study that includes a magnetic resonance imaging (MRI) apparatus and an MRI-compatible single-photon nuclear imaging apparatus imbedded within the RF coil of the MRI system such that sequential or simultaneous imaging can be done with the two modalities using the same support bed of the object under study during the imaging session.

A magnetic resonance imaging apparatus includes an imaging condition setting unit, a scan performing unit and a blood flow image generating unit. The imaging condition setting unit sets a sequence accompanying application of a motion probing gradient pulse as an imaging condition. The scan performing unit performs an imaging scan according to the sequence. The blood flow image generating unit generates a blood flow image based on data acquired by the imaging scan.

In a method and apparatus for MR imaging, a data acquisition sequence is executed wherein at least two slices of an examination subject are imaged in parallel with a gradient echo method for spatially resolved quantification of the T1 relaxation time.At least one first acquisition sequence is implemented to acquire MR data from a first slice of the examination subject and at least one second acquisition sequence is implemented to acquire MR data from a second slice of the examination subject. The acquisition sequences each include an inversion pulse and at least two successive readout steps. The first and second acquisition sequences are temporally offset from one another such that they at least partially overlap.

A system and method are provided to detect target analytes based on magnetic resonance measurements. Magnetic structures produce distinct magnetic field regions having a size comparable to the analyte. When the analyte is bound in those regions, magnetic resonance signals from the sample are changed, leading to detection of the analyte.

A magnetic resonance imaging apparatus includes an acoustic control unit and an image data acquisition unit. The acoustic control unit applies a gradient magnetic field for controlling a sound in synchronized with a signal representing a respiratory body motion. The image data acquisition unit acquires imaging data by imaging subsequently to controlling the sound and generates image data based on the imaging data.

A high magnetic susceptibility nanomagnetic material that may be attached to recognition molecules and other therapeutic biological materials so as to be targeted to specific biologic tissues, thereby enabling the presence of the targeted tissue to be detected under magnetic resonance imaging with much greater sensitivity. Also a stent coated with such nanomagnetic material to enable artifact free imaging of such stent under magnetic resonance imaging.

The invention relates to a non-convex low-rank reconstruction method for rapid MR imaging. An MR image data reconstruction mathematic model based on low-rank prior information of non-local similar image blocks is established, and iterative solution is carried out on the model in a direction alternative iteration method; a non-convex p norm of the low-rank matrix of the non-local image model with the low-rank prior information is solved by deposition and iteration of Taylor first-order approximation and the singular value, a similar image block is obtained, and a reconstruction image is solved via iteration by increasing the auxiliary variable and separating the variable. The image prior information is used to combine the non-local similarity with the low-rank characteristic of the image block, the Fourier transform and the characteristic of the low-rank matrix are used to simplify the calculation process, the complexity of algorithm is reduced, the performance of the reconstructed MRI images by part of K space data is improved, the image can be reconstructed more accurately with less scanning and measurement, pseudo shadows of the images are reduced, and rapid MRI is realized.

Nuclear magnetic resonance systems and methods of use thereof are provided. The systems employ implantable radiofrequency coils (105) and optionally implantable magnets (101). The systems can employ weak permanent magnets and / or permanent magnets that provide magnetic fields that are much less homogeneous than in conventional systems. This allows, for example, for inexpensive and simple probeheads for nuclear magnetic resonance relaxometry with suitable biosensors. The methods of the present invention allow in-vivo magnetic resonance measurements and, in particular, monitoring of analytes and determination of medical diagnostic information, for example, based on determined magnetic resonance parameters.

The MRI apparatus of the present invention performs a pulse sequence for applying successively 180° pulses 102, 103 . . . after application of a 90° pulse 101 at constant intervals and applying readout magnetic fields 111 during the interval between pairs of 180° pulses while the polarity of the magnetic field 111 is inverted several times to collect a plurality of gradient echo signals that are phase encoded differently. Here, the application of the readout gradient magnetic field is controlled such that generation of the gradient echo signals does ot coincide with generation of the spin echo signal. The image reconstruction is performed by using only T2* weighted gradient echo signals to obtain images reflecting difference in magnetic susceptibility and inhomogeneities in local magnetic fields.

In a method and magnetic resonance (MR) for correction of movement in the acquisition of MR images of an examination region, wherein the movement that occurs between the acquisition of data of spatially different slices of the examination region is taken into account, data from the examination region are acquired in multiple slices that are acquired in at least two groups, with slices of a second group arranged at least partially between slices of the first group, such that at least one slice of the second group lies between slices of the first group. Correction for movement of the examination region that occurred between the acquisition of data of the slices of the first group and the acquisition of data of an intervening slice of the second group is done by reconstructing a reference data set for the intervening slice from acquired slice data of the first group for the movement correction. This reference data set is compared with data of the acquisition of the MR image of the intervening slice in order to determine and correct the occurred movement.

Provided is a system and method for performing a magnetic resonance fingerprinting imaging process. The process includes determining acquisition parameters including at least one of repetition time (TR) or flip angle (FA), selected to control one of a duration and a number of repetitions of for a pulse sequence that samples k-space in a Cartesian acquisition pattern by acquiring an echo train. The process also includes controlling a magnetic resonance imaging (MRI) system to perform the pulse sequence a plurality of times to acquire magnetic resonance fingerprinting (MRF) data corresponding to signals from the subject excited by the pulse sequence. The process also includes estimating quantitative tissue properties of the subject by comparing the MRF data to a database and reconstructing, from the MRF data, at least one image of the subject indicating the estimated quantitative tissue properties.

The invention relates to a method for partitioning brainstem areas automatically from MR (magnetic resonance) sequence images. The method is used for partitioning the brainstem areas automatically and continuously from the human body encephalic MR sequence images, so as to offer technological bases for reconstruction of 3D model of the encephalic tissues to doctors to judge the state of an illness of the patient efficiently and intuitively. The method comprises steps of (1) preprocessing: carrying out gray level clustering analysis on all MR nerve sequence images, and clustering the gray levels of all the MR images to be processed to be five-level gray level images; (2) selecting seed point pixel, obtaining the outline border of the brainstem area of the first MR image through a neighbor region growing algorithm based on the image area growing rate; (3) roughly partitioning the current MR image through a block region growing method; (4) repartitioning the roughly partitioned MR images through logical judgment treatment and the region growing method; and (5) repeating the step (3) and the step (4) till finishing partitioning all MR images.

A magnetic resonance imaging apparatus includes a collection unit which applies a uniform static magnetic field to a subject and also applies a radio-frequency magnetic field and a gradient magnetic field to the subject in accordance with a predetermined pulse sequence to collect a magnetic resonance signal from the subject, a imaging unit which images the subject based on the magnetic resonance signal collected by the collection unit, a detection unit which detects a respiratory level of the subject, an informing unit which informs the subject of whether the detected respiratory level falls within an allowable range, and a unit which controls the collection unit and the imaging unit in such a manner that the magnetic resonance signal for imaging is collected and the subject is imaged based on the thus collected magnetic resonance signal for imaging when the detected respiratory level falls within the allowable range.

The invention discloses a lung rapid magnetic resonance imaging method based on prior knowledge and sparse sampling. A hyperpolarization gas contrast medium makes lung magnetic resonance imaging possible. In the imaging process, an imaging object needs to hold the breath to reduce generation of motion artifacts, the polarizability of hyperpolarization gas is attenuated rapidly along with the time, the signal-to-noise ratio of the image is reduced, and therefore great significance for improvement of the imaging speed is achieved. According to the lung rapid magnetic resonance imaging method, firstly hydrogen proton magnetic resonance imaging is carried out on the lung area firstly, the prior information of signal distribution of the lung area is extracted through an image processing method, a self-adapting hyperpolarization gas sparse sampling pulse sequence is generated according to the prior information, and the lung is imaged after the imaging object inhales the hyperpolarization gas. The sampling points are reduced, so that the imaging time is shortened. Due to the guidance of the prior information, the polarizability of the gas contrast medium is used more reasonably, and the image quality is equal to or better than that of a full-sampling method.

The disclosed embodiments provide a method for acquiring MR data at resolutions down to tens of microns for application in in-vivo diagnosis and monitoring of pathology for which changes in fine tissue textures can be used as markers of disease onset and progression. Bone diseases, tumors, neurologic diseases, and diseases involving fibrotic growth and / or destruction are all target pathologies. Further the technique can be used in any biologic or physical system for which very high-resolution characterization of fine scale morphology is needed. The method provides rapid acquisition of selected values in k-space, with multiple successive acquisitions of individual k-values taken on a time scale on the order of microseconds, within a defined tissue volume, and subsequent combination of the multiple measurements in such a way as to maximize SNR. The reduced acquisition volume, and acquisition of only select values in k-space along selected directions, enables much higher in-vivo resolution than is obtainable with current MRI techniques.

A technique for improving accuracy of temperature measurement in a living body using MRS / MRSI is provided. A cerebrospinal fluid suppression sequence that does not affect nuclear magnetic resonance signals of metabolite, but suppresses nuclear magnetic resonance signals of cerebrospinal fluid is executed in advance of execution of a signal measurement sequence for measuring nuclear magnetic resonance signals of water and a desired metabolite. There are thereby obtained spectra of water and the metabolite obtained from the nuclear magnetic resonance signals of water and the metabolite in which nuclear magnetic resonance signals of cerebrospinal fluid is suppressed. The obtained spectral peaks are fitted to a model function to obtain resonant frequencies of water and the metabolite, and the difference thereof is used to calculate temperature.

In a method and a magnetic resonance (MR) system, a marked area is determined that demarcates a predetermined volume segment of the subject relative to the regions adjacent thereto. Nuclei in the predetermined volume segment are excited, or nuclei in a region adjacent thereto are saturated with an RF excitation pulse at the same time a magnetic field gradient is activated. The center frequency of a frequency range of the RF excitation pulse and the direction of the magnetic field gradient are adjusted dependent on resonant frequencies of substances present within the predetermined volume segment in order, starting from the predetermined volume segment to shift an actual excitation volume segment excited by the RF excitation pulse toward the marked area, or to shift a saturation volume saturated by the RF excitation pulse away from the marked area. MR data are then acquired from the predetermined volume segment.

A magnetic resonance imaging apparatus includes a data acquisition unit, a correction unit, a sorting unit and n image reconstruction unit. The data acquires data for imaging and projection data. The correction unit performs motion correction of the data using the breath levels obtained based on the projection data. The data sorting unit sorts the data after the motion correction into a cardiac time phase order based on electrocardiographic information. The image reconstruction unit reconstructs three dimensional image data based on the sorted data after the motion correction.

The disclosed embodiments provide a method for acquiring MR data at resolutions down to tens of microns for application in in-vivo diagnosis and monitoring of pathology for which changes in fine tissue textures can be used as markers of disease onset and progression. Bone diseases, tumors, neurologic diseases, and diseases involving fibrotic growth and / or destruction are all target pathologies. Further the technique can be used in any biologic or physical system for which very high-resolution characterization of fine scale morphology is needed. The method provides rapid acquisition of selected values in k-space, with multiple successive acquisitions of individual k-values taken on a time scale on the order of microseconds, within a defined tissue volume, and subsequent combination of the multiple measurements in such a way as to maximize SNR. The reduced acquisition volume, and acquisition of only select values in k-space along selected directions, enables much higher in-vivo resolution than is obtainable with current MRI techniques.

The invention provides magnetic resonace imaging apparatus and magnetic resonance imaging method. A magnetic resonance imaging apparatus includes a trigger generating unit, a blood flow image generating unit and a control unit. The trigger generating unit acquires blood flow information of an object and generates a trigger based on the blood flow information. The blood flow image generating unit acquires imaging data with using the trigger and generates blood flow image data. The control unit controls so as to repeatedly perform a probe sequence for acquiring the blood flow information and animaging sequence for acquiring the imaging data alternately.

In a method to control a magnetic resonance system to generate magnetic resonance exposures of an examination subject, a first magnetic resonance radio-frequency pulse with a pulse length of at most 50 μs is initially emitted in a volume region of the examination subject. At least one second magnetic resonance radio-frequency pulse, whose phase is essentially rotated by 180° relative to the first magnetic resonance radio-frequency pulse, with a pulse length of at most 50 μs, is emitted in the same volume region of the examination subject in a predetermined time interval immediately after the first magnetic resonance radio-frequency pulse. An acquisition of raw data from the volume region of the examination subject then takes place. Furthermore, a control device for operating a magnetic resonance system as well as a magnetic resonance system with such a control device to implement such a method, are described.

A method and device for establishing a protocol relating to a measurement sequence for controlling a magnetic resonance tomography system, the measurement sequence is segmented into various groups of partial modules that are similar to one another. A partial module that potentially generates the greatest physiological exposure for a patient is identified. Furthermore, a test is carried out by means of a model function to determine whether physiological limiting values are being observed in the measurement sequence for the partial module. If the physiological limiting values are not being observed, parameters influencing the measurement sequence are modified and the preceding test step is repeated.

The invention provides a contrast agent which comprises water and nanoparticles suspending in water and with a gold nano-cluster as a core and a diethylenetriamine pentaacetic acid-gadolinium chelating agent as a shell. The gold nano-cluster has the functions of near infrared fluorescence (NIR) and computed tomography (CT) imaging; gadolinium is a rare earth element responsive to nuclear magnetic resonance, and the diethylenetriamine pentaacetic acid-gadolinium chelating agent has a magnetic resonance imaging (MIR) function; the contrast agent provided by the invention fuses the gold nano-cluster and the gadolinium chelating agent together, is capable of NIR / CT / MRI three-mode radiography and can fuse near infrared fluorescence, computed tomography imaging and magnetic resonance imaging together. Furthermore, the nanoparticles have a diameter of mere 0.9 to 1.1 nm, so the contrast agent is hardly phagocytosed by a reticuloendothelial system (RES) of a living body and has high permeability and improved radiographic sensitivity. The invention also provides a preparation method for the contrast agent.

The invention belongs to the field of bio-medicine, and discloses a magnetic resonance imaging nano-carrier, a nano drug carrier system and a preparation method thereof. According to the invention, two targeting molecules, namely folic acid and cell-penetrating peptide, are adopted, so that a targeting effect on tumors is improved, and meanwhile, anti-tumor activity in vitro and in vivo is enhanced. PLGA, which is low in toxicity and good in biocompatibility, is taken as the anti-tumor drug carrier, and the terminal of the PLGA is modified with CS, so that the functional nano-system is prepared. Meanwhile, nuclear magnetic imaging drugs and anti-tumor drugs are effectively loaded, so that the anti-tumor drugs can reach a tumor focus part in a specific mode, and tumor region nuclear magnetic localization of ferroferric oxide nanoparticles can be implemented; and meanwhile, a therapeutic effect with high selectivity and low toxicity can be achieved. With the application of the invention,shortcomings of conventional cytotoxic drugs which are poor in selectivity, relatively strong in toxic and side effects, capable of causing drug tolerance easily and the like can be overcome; and a utilization degree of the anti-tumor drugs can be improved and toxic and side effects can be reduced. The preparation method of the drug carrier system is simple and easy to implement; and the preparedproduct (the drug carrier system) is good in repeatability and stability.